glp-1 agonist pharmacology Glucagon-like peptide-1 Science Behind GLP 1 GIP

PMCID: PMC3349454

Clinical observations suggest that headaches can be improved through dietary and pharmaceutical weight management

Obesity and meningioma: a US population-based study paired with analysis of a multi-institutional cohort

Patients who view treatment as short-term may be less prepared for the long-term commitment required to maintain results

Unlike injectable GLP-1s, orforglipron is a once-daily oral agent, offering an alternative for patients averse to injections

Effectiveness of glucose-lowering medications on cardiovascular outcomes in patients with type 2 diabetes at moderate cardiovascular risk